Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

 		Prostatic Neoplasms, Castration-Resistant Phase1 Australia
South Africa

Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

 		Allergy, Peanut Phase2 United States

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Adolescent ORION-16 or ORION-13 Studies

 		Heterozygous or Homozygous Familial Hypercholesterolemia Phase3 United States
Spain
Netherlands
Turkey
Lebanon
South Africa
Brazil
Germany
Poland
Switzerland
Israel
Malaysia
Slovenia
United Kingdom
Italy
Norway
Hungary
Canada
Taiwan
France
View All

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

 		Glioblastoma Phase1 United States
Spain
France
Switzerland
Portugal
View All

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

 		Prostatic Neoplasm Phase2 France
Netherlands
Spain
China
Poland
Italy
Canada
Czechia
Korea, Republic of
Singapore
United States
View All

Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma

 		Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Phase1 Italy
Germany
Spain
China
Korea, Republic of
Singapore
View All

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

 		Breast Cancer Russian Federation

Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

 		Relapsing Multiple Sclerosis Austria

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

 		Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase2 Spain
France

A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma

 		Spinal Muscular Atrophies Brazil